70% Neck Pain Reduction with Biologic Disc Repair: How a Multilevel Cervical Disc Disease Patient Avoided Two-Level Fusion

A registered nurse in her early 50s with multilevel cervical disc disease at C5-C6 and C6-C7, daily cervicogenic headaches, and left-arm radicular symptoms reduced her neck pain by roughly 70% and avoided a planned two-level anterior cervical discectomy and fusion through intra-annular fibrin injection at ValorSpine. This case study walks through her baseline, the biologic disc repair approach, recovery timeline, and outcomes at one year.

This case study is part of our Cervical Spine and Neck Pain pillar, which catalogs non-surgical and biologic options for chronic neck pain. It sits inside our broader spinal fusion alternatives framework and complements our patient story on cervical radiculopathy treated with fibrin.

Summary Box

Context and Baseline

The patient is an anonymized registered nurse in her early 50s who had spent more than two decades in bedside roles — medical-surgical units, then post-anesthesia recovery. The role demanded constant patient transfers, repeated overhead reaching to adjust IV poles and monitors, and long shifts in awkward postures. Over the previous six years, she developed progressive neck pain that eventually became daily and severe.

By the time she presented to ValorSpine, her symptoms included:

• Constant axial neck pain rated 72 mm on a 100 mm visual analog scale (VAS) — in the same severe range reported in published intra-annular fibrin cohorts at baseline.
• Daily cervicogenic headaches starting at the suboccipital region and wrapping forward.
• Intermittent left-sided radicular pain into the lateral arm, with tingling along the dorsal forearm and into the middle finger — a C7 distribution.
• Loss of cervical rotation, particularly to the left, that interfered with driving, charting, and sleeping.

MRI demonstrated multilevel cervical disc degeneration with posterior annular fissures at C5-C6 and C6-C7, mild central canal narrowing, and a small left paracentral disc protrusion at C6-C7 contacting the C7 nerve root. There was no myelopathic compression and no significant spondylolisthesis.

Her treating spine surgeon recommended a two-level anterior cervical discectomy and fusion from C5 to C7. She declined. Three concerns drove that decision: the documented risk of adjacent segment disease above and below fused segments, the typical 3- to 6-month or longer recovery from cervical fusion, and her awareness that roughly 40% of back and neck surgeries do not achieve the patient’s desired outcome. She also knew that nearly 1 in 5 patients told they need spine surgery decline it, and she had decided she would be one of them before exhausting biologic options.

Functional Baseline

• Unable to work full 12-hour shifts; reduced to 8-hour shifts with restricted lifting.
• Driving tolerated for less than 20 minutes before symptom flare.
• Sleep disrupted nightly; she had cycled through three pillow types without lasting benefit.
• Daily NSAID use plus intermittent muscle relaxants and gabapentin for radicular symptoms.

Approach

The ValorSpine evaluation focused on confirming that the cervical discs themselves were the dominant pain generators — not facet joints, muscle, or referred pain from the shoulder. This is the central diagnostic question for any candidate considering biologic disc repair as an alternative to fusion.

Three steps drove the decision-making:

1. Targeted clinical examination. Spurling test reproduced her radicular pain on the left. Cervical extension reproduced axial pain. Shoulder examination was unremarkable, lowering the probability of a primary shoulder pain generator.
2. Imaging review. MRI findings at C5-C6 and C6-C7 were reviewed with the patient slice by slice, focusing on the posterior annular signal changes (high-intensity zones) consistent with annular tear repair candidates.
3. Provocation discography. Concordant pain was reproduced at C5-C6 and C6-C7 at low pressures, with a non-painful control level above. This confirmed both segments as symptomatic discogenic pain sources and qualified her for intra-annular fibrin injection.

Once the discs were confirmed as the pain source, the team and the patient compared three pathways:

• Repeat conservative care — she had already exhausted physical therapy, chiropractic care, two cervical epidural steroid injections, and pharmacologic management. AAFP systematic reviews found epidural steroid injections not effective for chronic low back pain on their own, and her cervical injection results echoed that limited response.
• Two-level ACDF as recommended elsewhere — rejected by the patient.
• Intra-annular fibrin injection at C5-C6 and C6-C7 — selected. This is a minimally invasive biologic disc repair procedure designed to seal painful annular tears and create a scaffold for natural healing within the disc itself, while preserving motion at both segments.

For broader context on how biologic disc repair compares with surgical approaches, see our explainers on cervical fusion vs. biologic disc repair and ACDF vs. cervical disc replacement.

Implementation

Procedure Day

The intra-annular fibrin injection was performed in a sterile suite under fluoroscopic guidance with mild conscious sedation. A spinal needle was advanced anterolaterally into each target disc — first C5-C6, then C6-C7 — with imaging confirmation at every stage. Once intra-discal positioning was verified, the fibrin solution was delivered into the annular wall to seal the documented fissures. Total procedure time was approximately 75 minutes, including positioning and recovery monitoring.

Post-Procedure Protocol

Recovery was structured in four phases. The patient adhered closely to each, which is consistent with what the ValorSpine team has observed across cervical cases — protocol adherence correlates with outcomes.

• Weeks 1–2 — Protected rest. No lifting over 5 pounds. No overhead work. Soft cervical collar permitted for travel and prolonged sitting only. Short walks several times daily.
• Weeks 3–6 — Graduated mobility. Gentle cervical range-of-motion drills, scapular setting exercises, and isometric deep-neck-flexor activation. Driving reintroduced for trips under 30 minutes.
• Months 2–4 — Cervical-specific rehabilitation. Supervised physical therapy two times per week emphasizing deep neck flexor endurance, mid-thoracic mobility, and ergonomic retraining for nursing-specific tasks (transfers, IV pole reach, charting posture).
• Months 4–12 — Return to full duty. Stepwise return to 12-hour bedside shifts with attention to body mechanics during transfers and a hard rule against single-person heavy lifts.

Workplace Modifications

The patient negotiated three durable changes with her employer: mandatory two-person transfers for any patient over 200 pounds, a height-adjustable charting station, and a mid-shift micro-break protocol that her unit eventually adopted more broadly. These were not therapeutic in themselves but reduced repeat exposure to the loading patterns that had driven her degeneration.

For desk-bound readers, our guide on protecting your cervical spine at a desk covers parallel ergonomic principles.

Results

Outcomes were tracked at 4 weeks, 3 months, 6 months, and 12 months. The trajectory mirrored what published intra-annular fibrin cohorts describe — gradual, durable improvement rather than an immediate switch from pain to no pain.

Her 12-month VAS reduction of approximately 70% (from 72 mm to 22 mm) is consistent with the magnitude reported in published intra-annular fibrin studies, where average pain scores improved from 72.4 mm at baseline to 33.0 mm at 104 weeks. Patient satisfaction in those same cohorts ran near 70% at 2-year follow-up, and 80% of failed-back-surgery patients reported positive outcomes — a useful comparator even though this patient had not yet had cervical surgery.

Most importantly, she did not undergo the recommended two-level fusion. By preserving motion at C5-C6 and C6-C7, she also avoided the cascade of accelerated wear at adjacent segments above C5 and below C7 that drives many revision procedures. Revision surgery rates after fusion can exceed 20% within 10 years, and that statistic was central to her decision-making.

Expert Take

Multilevel cervical cases used to be considered automatic surgical candidates. Concordant discography combined with intra-annular fibrin injection has changed the calculus for a meaningful subset of these patients — particularly those without myelopathy, without severe instability, and with annular tear pathology visible on MRI. The patient’s clinical profile here is increasingly common: a healthcare worker with cumulative occupational load, severe symptoms, an articulate decision to avoid fusion, and the patience to follow a months-long recovery protocol.

Lessons Learned

Five takeaways stand out from this case for clinicians, patients, and referrers.

1. Discography matters. MRI shows structural change; provocation discography demonstrates which structural changes actually generate the patient’s pain. Without that confirmation, biologic disc repair is a guess.
2. Multilevel does not automatically mean fusion. Treating two adjacent symptomatic discs biologically is feasible and preserves motion at both. The alternative — a two-level fusion — commits the patient to permanent loss of motion at both segments and increased load on neighbors.
3. Patient-driven decisions hold up. The patient declined surgery before her ValorSpine consultation. That conviction made it easier to commit to a slower biologic recovery rather than abandoning the protocol mid-course.
4. Recovery is gradual, not linear. Early-week soreness, week 3–4 plateau, and month-2 inflection are typical. Coaching patients through that arc reduces premature dissatisfaction.
5. Workplace ergonomics are part of the treatment. Returning to the same loading pattern that produced the disease undermines biologic repair. Real, enforceable workplace modifications were as important to the 12-month result as the procedure itself.

Transparency

Three points the team would emphasize for future cases of this profile:

• The patient’s outcome is favorable but represents one case. Published cohorts and her result align in direction and magnitude, but individual outcomes vary.
• Headache reduction was a secondary outcome. The procedure targets the disc; cervicogenic headache improvement appears to follow when the disc-driven inflammatory and mechanical inputs settle, but it is not guaranteed.
• If concordant discography had been negative or equivocal, fibrin injection would not have been offered. Patient selection is the single largest determinant of outcomes.

Patients with related cervical pathology can compare alternatives in our overviews of non-surgical cervical neck pain treatments and cervical pain treatment options ranked. Patients evaluating their cause-of-pain question should also see top causes of chronic neck pain and cervical conditions causing neck pain. For patients who arrived with prior surgery, the bridge case is our failed back surgery fibrin case study.

Frequently Asked Questions

Is intra-annular fibrin injection a fusion alternative for multilevel cervical disc disease?

Yes. For patients with painful annular tears at adjacent cervical levels confirmed by provocation discography, intra-annular fibrin injection treats both discs in a single session while preserving motion. It avoids the loss of segmental movement and the risk of adjacent segment disease that follow multilevel fusion. Candidacy depends on imaging, neurologic findings, and concordant discography results.

How quickly do patients feel relief after cervical fibrin disc treatment?

Relief is gradual. Most patients describe early soreness in the first 1–2 weeks, modest improvement by week 6, meaningful reduction in pain by 3 months, and continued gains through 6–12 months. Published cohorts show VAS pain scores moving from 72.4 mm at baseline to 33.0 mm at 104 weeks, which matches what this patient experienced.

What disqualifies a patient from biologic disc repair in the cervical spine?

Significant cord compression with myelopathy, severe instability, fracture, infection, tumor, and severe disc collapse without remaining annular substrate are the primary disqualifiers. Negative or non-concordant discography also disqualifies a patient, because the procedure should only target discs proven to generate pain.

Does the procedure help cervicogenic headaches?

Often, yes — as a secondary effect. When the cervical disc is the upstream driver of inflammatory signaling and mechanical irritation, sealing the annular tear and reducing disc-driven pain frequently lowers headache frequency. The procedure is not a primary headache treatment, but headache improvement is a common reported outcome in disc-driven cervicogenic cases.

What if my surgeon has already recommended two-level ACDF?

A surgical recommendation is not a verdict. Nearly 1 in 5 patients told they need spine surgery decline it, and roughly 40% of back and neck surgeries do not achieve the desired outcome. A second opinion focused on biologic candidacy — including provocation discography — is the standard next step for patients who want to confirm whether a non-fusion path is reasonable in their specific case.

Sources and Further Reading

• American Academy of Family Physicians (AAFP) — systematic review on the limited efficacy of epidural steroid injections for chronic spinal pain in isolation.
• National Institute of Neurological Disorders and Stroke (NINDS) — reference material on cervical disc disease, radiculopathy, and conservative care.
• Journal of Neurosurgery — published outcome data on cervical fusion, adjacent segment disease, and revision rates.
• Peer-reviewed cohort data on intra-annular fibrin injection — reporting baseline VAS of 72.4 mm improving to 33.0 mm at 104 weeks and ~70% patient satisfaction at 2-year follow-up.
• U.S. Department of Veterans Affairs — population-level musculoskeletal pain prevalence and severe pain disparities relevant to comparison with civilian healthcare worker cohorts.
• Published clinical literature on cervicogenic headache as a secondary outcome of cervical disc-targeted intervention.

Next Steps

If you have been told you need cervical fusion — especially multilevel fusion — and you want to know whether biologic disc repair is a reasonable alternative in your specific case, the deciding question is whether your discs are the confirmed pain source. Provocation discography answers it.

Ready to explore non-surgical options for your back pain? Schedule your consultation with ValorSpine today. Visit valorspine.com/contact to begin.